Gairola Shruti, Solanki Sohan Lal, Patkar Shraddha, Goel Mahesh
Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra India.
Division of Hepatobiliary Surgical Oncology, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra India.
Indian J Surg Oncol. 2024 May;15(Suppl 2):186-195. doi: 10.1007/s13193-024-01883-4. Epub 2024 Jan 23.
Artificial intelligence (AI) is a speciality within computer science that deals with creating systems that can replicate the intelligence of a human mind and has problem-solving abilities. AI includes a diverse array of techniques and approaches such as machine learning, neural networks, natural language processing, robotics, and expert systems. An electronic literature search was conducted using the databases of "PubMed" and "Google Scholar". The period for the search was from 2000 to June 2023. The search terms included "artificial intelligence", "machine learning", "liver cancers", "liver tumors", "hepatectomy", "perioperative" and their synonyms in various combinations. The search also included all MeSH terms. The extracted articles were further reviewed in a step-wise manner for identification of relevant studies. A total of 148 articles were identified after the initial literature search. Initial review included screening of article titles for relevance and identifying duplicates. Finally, 65 articles were reviewed for this review article. The future of AI in liver cancer planning and management holds immense promise. AI-driven advancements will increasingly enable precise tumour detection, location, and characterisation through enhanced image analysis. ML algorithms will predict patient-specific treatment responses and complications, allowing for tailored therapies. Surgical robots and AI-guided procedures will enhance the precision of liver resections, reducing risks and improving outcomes. AI will also streamline patient monitoring, better hemodynamic management, enabling early detection of recurrence or complications. Moreover, AI will facilitate data-driven research, accelerating the development of novel treatments and therapies. Ultimately, AI's integration will revolutionise liver cancer care, offering personalised, efficient and effective solutions, improving patients' quality of life and survival rates.
人工智能(AI)是计算机科学中的一个专业领域,涉及创建能够复制人类思维智能并具备问题解决能力的系统。人工智能包括机器学习、神经网络、自然语言处理、机器人技术和专家系统等多种技术和方法。使用“PubMed”和“谷歌学术”数据库进行了电子文献检索。检索时间段为2000年至2023年6月。检索词包括“人工智能”、“机器学习”、“肝癌”、“肝肿瘤”、“肝切除术”、“围手术期”及其各种组合的同义词。检索还包括所有医学主题词(MeSH)。对提取的文章进行逐步审查以确定相关研究。初步文献检索后共识别出148篇文章。初步审查包括筛选文章标题的相关性并识别重复项。最后,对65篇文章进行了本综述文章的审查。人工智能在肝癌规划和管理中的未来前景广阔。人工智能驱动的进步将越来越能够通过增强的图像分析实现精确的肿瘤检测、定位和特征描述。机器学习算法将预测患者特异性的治疗反应和并发症,从而实现个性化治疗。手术机器人和人工智能引导的手术将提高肝切除的精度,降低风险并改善治疗效果。人工智能还将简化患者监测,更好地进行血流动力学管理,实现复发或并发症的早期检测。此外,人工智能将促进数据驱动的研究,加速新治疗方法的开发。最终,人工智能的整合将彻底改变肝癌治疗,提供个性化、高效且有效的解决方案,提高患者的生活质量和生存率。